Analysis of caffeine as a treatment for attention deficit disorder with hyperactivity: a literature review
DOI:
https://doi.org/10.33448/rsd-v11i15.37298Keywords:
Caffeine; Attention deficit disorder with hyperactivity; ADHD; Therapeutics; Methylphenidate.Abstract
Introduction: Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder that affects children, adults and the elderly worldwide, with multifactorial origins. Currently, therapy is performed with drugs derived from amphetamines, however, other substances have received attention, such as caffeine, which has pharmacological action through antagonism of adenosine receptors, being a possible treatment for ADHD. Objective: To analyze the possible effects of caffeine as a possible therapeutic option in ADHD. Methodology: This is a literature review focusing on the analysis of the effects of caffeine as a possible treatment for ADHD. Using descriptors like "caffeine"; "ADHD"; "therapeutics"; “methylphenidate” and “attention hyperactivity disorder” in the Scientific Electronic Library of Medicine (SCIELO), National Library of Medicine (PubMed MEDLINE) and Virtual Health Library (BVS) databases. Results and Discussion: Caffeine, when administered together with amphetamines, tended to be potentiated by caffeine due to cross-sensitization. In rodents, they showed significant results in alertness. In humans, positive results have also been demonstrated by facilitating the release of neurotransmitters responsible for controlling motor functions and well-being. Conclusion: Although there are benefits of caffeine in the treatment of the disorder, however, caffeine had certain adverse effects, in addition to the fact that there are not many current studies in humans. For this, further studies in humans are needed to prove its efficacy and safety in ADHD, contributing to the therapeutic evolution of this disorder.
References
American Psychiatric Association (APA). Manual diagnóstico e estatístico de transtornos mentais: DSM-5. (5a ed.), Artmed, 2014.
Biederman, J., Faraone, S. V, Keenan, K., Benjamin, J., Krifcher, B., Moore, C., Sprich-Buckminster, S., Ugaglia, K., Jellinek, M. S., Steingard, R., Spencer, T., Norman, D., Kolodny, R., Kraus, I., Perrin, J., Keller, M. B., Tsuang, M. T., Service Biederman, P., Keenan, M. (1992). Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder patterns of comorbidity in probands and relatives in psychiatrically and pediatrically referred samples. The Pediatric Psychopharmacology Unit, 49(9), 728-738. http://archpsyc.jamanetwork.com/.
Biederman, J., Faraone, S. V., Keenan, K., Knee, D., Tsuang, M. T. (1990). Family-Genetic and Psychosocial Risk Factors in DSM- III Attention Deficit Disorder. J. Am. Acad. Child Adolesc. Psychiatry, 29 (4), 526-533. https://doi.org/10.1097/00004583-199007000-00004.
Boeck, C. R., Marques, V. B., Valvassori, S. S., Constantino, L. C., Rosa, D. V. F., Lima, F. F., Romano-Silva, M. A., & Quevedo, J. (2009). Early long-term exposure with caffeine induces cross-sensitization to methylphenidate with involvement of DARPP-32 in adulthood of rats. Neurochemistry International, 55(5), 318–322. https://doi.org/10.1016/j.neuint.2009.03.015.
Castro, C. X. L & Lima, R. F. (2018). Consequências do transtorno do déficit de atenção e hiperatividade (TDAH) na idade adulta. Revista Psicopedagogia, 35(106), 61-72. http://pepsic.bvsalud.org/pdf/psicoped/v35n106/08.pdf.
Cipollone, G., Gehrman, P., Manni, C., Pallucchini, A., Maremmani, A. G. I., Palagini, L., Perugi, G., & Maremmani, I. (2020). Exploring the role of caffeine use in adult-ADHD symptom severity of US army soldiers. Journal of Clinical Medicine, 9(11), 1–10. https://doi.org/10.3390/jcm9113788.
Coelho, F. J. F., Santos, G. S & Silva, M. L. (2020). Gostaria de um cafezinho, um chá ou um refrigerante? O uso da cafeína na perspectiva da Redução de Danos entre jovens e adultos. Research, Society and Development, 9(8), e221985625. https://doi.org/10.33448/rsd-v9i8.5625.
Conforto, C. E., Amaral, C. D., Silva, L. S. (2011). Roteiro para revisão bibliográfica sistemática: aplicação no desenvolvimento de produtos e gerenciamento de projetos. 8º congresso brasileiro de gestão de desenvolvimento de produto. https://www.researchgate.net/publication/267380020.
Couto, T. S., Junior, M. M. R. & Gomes, C. A R. (2010). Aspectos neurobiológicos do transtorno do déficit de atenção e hiperatividade (TDAH): uma revisão. Ciências & Cognição, 15 (1), 241-251. http://pepsic.bvsalud.org/pdf/cc/v15n1/v15n1a19.pdf.
De-la-Torre-Ugarte-Guanilo, M. C., Takahashi, R. F., & Bertolozzi, M. R. (2011). Revisão sistemática: noções gerais. Revista Da Escola de Enfermagem Da USP, 45(5), 1260–1266. https://doi.org/10.1590/S0080-62342011000500033.
Dias, T. (2017). Envolvimento do núcleo accumbens e da amígdala na neurobiologia dos transtornos do comportamento disruptivo e do transtorno de déficit de atenção/hiperatividade: um estudo de conectividade funcional de repouso em crianças [Tese de Doutoramento, Faculdade de Medicina da Universidade de São Paulo]. https://teses.usp.br/teses/disponiveis/5/5142/tde-14032018-123829/pt-br.php.
Faraone, S. V., Banaschewski, T., Coghill, D., Zheng, Y., Biederman, J., Bellgrove, M. A., Newcorn, J. H., Gignac, M., al Saud, N. M., Manor, I., Rohde, L. A., Yang, L., Cortese, S., Almagor, D., Stein, M. A., Albatti, T. H., Aljoudi, H. F., Alqahtani, M. M. J., Asherson, P., Wang, Y. (2021). The world federation of ADHD international consensus statement: evidence-based conclusions about the disorder. Neuroscience and Biobehavioral Reviews, 128(1), 789–818. https://doi.org/10.1016/j.neubiorev.2021.01.022.
França, A. (2018). Associação de cafeína e exercício físico como estratégia terapêutica nos prejuízos comportamentais e neuroquímicos observados em um modelo animal do Transtorno do Déficit de Atenção e Hiperatividade (TDAH). [Tese de Doutoramento, Universidade Federal de Santa Catarina]. https://repositorio.ufsc.br/handle/123456789/205853.
Garrett, B. E., Griffiths, R. R. (1997). The role of dopamine in the behavioral effects of caffeine in animals and humans. Pharmacology Biochemistry and Behavior, 57(3), 533-541. https://doi.org/10.1016/S0091-3057(96)00435-2.
Ioannidis, K., Chamberlain, S. R., & Müller, U. (2014). Ostracising caffeine from the pharmacological arsenal for attention-deficit hyperactivity disorder - Was this a correct decision? A literature review. Journal of Psychopharmacology, 28(9), 830–836. https://doi.org/10.1177/0269881114541014.
Killeen, R. P., Russell, A. V., & Sergeant, A. J. (2013). A behavioral neuroenergetics theory of ADHD. Neuroscience and Biobehavioral Reviews, 37(4), 625–657. https://doi.org/10.1016/j.neubiorev.2013.02.011.
Kolotilov, N. N. (2020). Drugs of radiological pharmacology reprofiling: caffeine. Radiation diagnostics, Radiation Therapy, 3(1), 57- 61. https://doi.org/10.37336/2707-0700-2020-3-6.
Lara, D. R. (2010). Caffeine, mental health, and psychiatric disorders. Journal of Alzheimer’s Disease, 20(1), 239-248. https://doi.org/10.3233/JAD-2010-1378.
Larsson, H., Chang, Z., D’Onofrio, B. M., & Lichtenstein, P. (2014). The heritability of clinically diagnosed attention deficit hyperactivity disorder across the lifespan. Psychological Medicine, 44(10), 2223–2229. https://doi.org/10.1017/S0033291713002493.
Leon, R. M. (2000). Effects of caffeine on cognitive, psychomotor, and affective performance of children with attention- deficit/hyperactivity disorder. Journal of Attention Disorders, 4 (1), 27-47. https://doi.org/10.1177/10870547000040010.
Lima, J. (2014). Contribuição de alimentos fonte para a ingestão dietética habitual estimada de metilxantinas no brasil e no município do Rio de Janeiro. [Dissertação de Mestrado, Universidade Federal do Rio de Janeiro]. http://www.ppgn.ufrj.br/wp-content/uploads/2020/06/Juliana-de-Paula-Lima-disserta%C3%A7%C3%A3o.pdf.
Loutfi, K. S & Carvalho, A. M. (2010). Possíveis interfaces entre TDAH e epilepsia. Jornal Brasileiro de Psiquiatria, 59(2), 146-155. https://doi.org/10.1590/S0047-20852010000200011.
Machado, M. A. da S., Machado, A. F., Campos, A. da S. F., & Felzenszwalb, I. (2021). Efeito da cafeína sobre a performance no treinamento intervalado de alta intensidade. Research, Society and Development, 10(8), e39610817413. https://doi.org/10.33448/rsd-v10i8.17413.
Matsumoto, J. (2012). Receptor A2a de adenosina: estudo da modulação da liberação de neurotransmissores em modelo in vitro. [Tese de Doutoramento, Instituto de Biociências da Universidade de São Paulo]. https://www.teses.usp.br/teses/disponiveis/41/41135/tde-03042013-115748/publico/JoaoPaulo_Matsumoto.pdf.
McLellan, M. T., Caldwell, A. J., Lieberman, R. H. (2016). A review of caffeine’s effects on cognitive, physical and occupational performance. Neuroscience and Behavioral Reviews, 71(1), 294-312. https://doi.org/10.1016/j.neubiorev.2016.09.001.
Mendes, M., Mourão, I. S. S., Tourinho, É. F., Barros, K. P. S., Silva, K. R. L., Mourão, P. A., Barros, P. S., Araujo, K. C., & Guimarães, M. S. V. S. (2021). TDAH: Transtorno e Déficit de Atenção e Hiperatividade. Research, Society and Development, 10(16), e305101623653. https://doi.org/10.33448/rsd-v10i16.23653.
Misra, A. L., Vadlamani, N. L., & Pontani, R. B. (1986). Effect of caffeine on cocaine locomotor stimulant activity in rats. Pharmacology Biochemistry & Behavior, 24(3), 761-764.https://doi.org/10.1016/0091-3057(86)90587-3.
Montenegro, M. (2020). Nem tudo é déficit de atenção. Campinas: Thieme Revinter.
Moschino, L., Zivanovic, S., Hartley, C., Trevisanuto, D., Baraldi, E., & Roehr, C. C. (2020). Caffeine in preterm infants: where are we in 2020. ERJ Open Research, 6(1), 330. https://doi.org/10.1183/23120541.00330-2019.
Pandolfo, P., Machado, N. J., Kofalvi, A., Takahashia, R. N., & Cunhab, R. A. (2013). Caffeine regulates frontocorticostriatal dopamine transporter density and improves attention and cognitive deficits in an animal model of attention deficit hyperactivity disorder. European Neuropsychopharmacology, 23(4), 317–328. https://doi.org/10.1016/j.euroneuro.2012.04.011.
Pina, R. M., Ramos, N. M., Rezende, F. A. P. (2021). Cafeína: consequências sobre o sistema nervoso e cardiovascular em indivíduos treinados-uma revisão da literatura [Monografia para Trabalho de Conclusão de Curso]. Centro Universitário de Brasília – UniCEUB. https://repositorio.uniceub.br/jspui/handle/prefix/15384.
Ranjbar-Slamloo, Y., & Fazlali, Z. (2020). Dopamine and noradrenaline in the brain; overlapping or dissociate functions. Frontiers in Molecular Neuroscience, 12(1), 334. https://doi.org/10.3389/fnmol.2019.00334.
Repantis, D., Bovy, L., Ohla, K., Kühn, S., & Dresler, M. (2021). Cognitive enhancement effects of stimulants: a randomized controlled trial testing methylphenidate, modafinil, and caffeine. Psychopharmacology Berlin, 238(2), 441-451. https://doi.org/10.1007/s00213-020-05691.
Santos, P. T & Francke, I. A. (2017). O transtorno déficit de atenção e os seus aspectos comportamentais e neuro-anatomo-fisiológicos: uma narrativa para auxiliar o entendimento ampliado do tdah. Revista Psicologia pt. https://www.psicologia.pt/artigos/textos/A1138.pdf.
Schnackenberg, C. R. (1973). Caffeine as a substitute for schedule II stimulants in hyperkinetic children. American Journal of Psychiatry, 130 (7), 796-798. https://doi.org/10.1176/ajp.130.7.796.
Shellenberg, T. P., Stoops, W. W., Lile, J. A., & Rush, C. R. (2020). An update on the clinical pharmacology of methylphenidate: therapeutic efficacy, abuse potential and future considerations. Expert Review of Clinical Pharmacology, 13(8), 825–833. https://doi.org/10.1080/17512433.2020.1796636.
Silva, J.C & Araújo, A. D (2017). A metodologia de pesquisa em análise do discurso. Grau Zero: Revista de Crítica Cultural, 5(1), 17-31. https://www.revistas.uneb.br/index.php/grauzero/article/view/3492.
Simola, N., Tronci, E., Pinna, A., & Morelli, M. (2006). Subchronic-intermittent caffeine amplifies the motor effects of amphetamine in rats. Amino Acids, 31(4), 359–363. https://doi.org/10.1007/s00726-006-0373-3.
Simon, V., Czobor, P., Bálint, S., Mészáros, Á., & Bitter, I. (2009). Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. British Journal of Psychiatry, 194(3), 204–211. https://doi.org/10.1192/bjp.bp.107.048827.
Souza, B. (2021). O potencial da associação de cafeína e exercício físico sobre prejuízos cognitivos observados em modelos animais do transtorno do déficit de atenção e hiperatividade (TDAH) [Dissertação de Mestrado, Universidade Federal de Santa Catarina]. https://repositorio.ufsc.br/handle/123456789/227269.
Trombini, C., & Oliveira, G. (2018). Atualização terapêutica sobre a cafeína. Revista Terra & Cultura, 29(57), 11-22. http://periodicos.unifil.br/index.php/Revistateste/article/view/170.
Vaidyanathan, S., Shah, H. & Gayal, T. (2016). Sleep Disturbances in Children with Attention-Deficit/ Hyperactivity Disorder (ADHD): Comparative Study with Healthy Siblings. J Can Acad Child Adolesc Psychiatry, 25 (3), 145-151. PMCID: PMC5130087.
Vanattou, N. S., McNamara, R., & Harkin, A. (2012). Caffeine provokes adverse interactions with 3,4- methylenedioxymethamphetamine (MDMA, ’ecstasy’) and related psychostimulants: Mechanisms and mediators. British Journal of Pharmacology, 167(5), 946–959. https://doi.org/10.1111/j.1476-5381.2012.02065.x.
Vázquez, J. C., Martin de la Torre, O., López Palomé, J., & Redolar-Ripoll, D. (2022). Effects of caffeine consumption on attention deficit hyperactivity disorder (ADHD) treatment: a systematic review of animal studies. Nutrients, 14 (4), 739. https://doi.org/10.3390/nu14040739.
Volkow, N. D., Wang, G. J., Logan, J., Alexoff, D., Fowler, J. S., Thanos, P. K., Wong, C., Casado, V., Ferre, S., & Tomasi, D. (2015). Caffeine increases striatal dopamine D2/D3 receptor availability in the human brain. Translational Psychiatry, 5(4). https://doi.org/10.1038/tp.2015.46.
Weibel, S., Menard, O., Ionita, A., Boumendjel, M., Cabelguen, C., Kraemer, C., Micoulaud-Franchi, J. A., Bioulac, S., Perroud, N., Sauvaget, A., Carton, L., Gachet, M., & Lopez, R. (2020). Practical considerations for the evaluation and management of attention deficit hyperactivity disorder (ADHD) in adults. Encephale, 46(1), 30–40. https://doi.org/10.1016/j.encep.2019.06.005.
White, B. C., & Keller, G. E. (1984). Caffeine pretreatment: enhancement and attenuation of d-amphetamine-induced activity’. Biochemistry & Behavior ,20(3), 383-386. https://doi.org/10.1016/0091-3057(84)90275-2.
Willcutt, E. G. (2012). The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics, 9(3), 490–499). https://doi.org/10.1007/s13311-012-0135-8.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Alex Alves da Silva; Douglas Lemes dos Santos; Geovana dos Santos Sousa; Emillin Freitas Alencar; Veronica de Franco Rennó
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
